Abstract
Introduction
Until ten years ago, almost all systematic reviews exclusively used standard pairwise meta-analysis. It is probably still the most frequent mode of meta-analysis in the literature. More recently, reviews have increasingly used network meta-analysis.
The first Cochrane review including a network meta-analysis was published in 2010 (Walsh et al., 2010) . Researchers conducting a systematic review have the choice between pairwise meta-analysis and network meta-analysis. Which method to use depends on the research question. Pairwise meta-analysis is the method of choice for researchers interested in a particular comparison, for example comparing a new treatment with a generally accepted standard of care, or asking whether a treatment is efficacious at all (compared to no treatment or placebo).
When searching the literature, reviewers planning a pairwise meta-analysis sometimes encounter multi-arm studies, where, say, two or more dosages of an interesting drug treatment are compared to a common control, for example placebo. If the research question is to compare the drug in all dosages to placebo, all comparisons (also called relative effects or contrasts) to placebo could and should be included in the same meta-analysis. However, as there is only one control group, one has to make sure that each patient enters the meta-analysis only once, in order to avoid a unit-of-analysis error. A unit-of-analysis error in a meta-analysis is said to occur if information from a treatment arm is used more than once or with disproportionate weight. For example, combining comparisons of three different dosages of an active treatment to the same full placebo group without any adjustment would mean using the patients of the placebo group thrice. This is a problem because comparisons using the same individuals are correlated. It is clearly a methodogical flaw. To avoid this, often the control group is randomly partitioned into two or more subgroups, each of which is compared to another active group. The shared group could also be the active group instead of the control group which is illustrated using a ficti-tious example in section 16.5.4 (How to include multiple groups from one study) of the Cochrane Handbook for Systematic Reviews of Interventions (Higgins and Green, 2011, Version 5.1.0) . The Cochrane Handbook provides general guidelines for meta-analysis with multiple treatment groups and lists a number of possible ways to include these data.
The first approach (which is recommended by Cochrane) is to combine all groups that represent different modalities of a treatment to a single large group. For the example, this results in combining two or more dosage groups. Technically, in the case of a binary outcome this is easily done by summing up the numbers of events and the total numbers of individuals across all groups involved. Section 7.7.3.8 of the Cochrane Handbook (Table 7 .7.a) provides formulas for calculating mean and standard deviation of a combined group in case of a continuous outcome, given summary data for the two groups that are to be combined. This can also be done using the calculator in RevMan 5.3 (The Cochrane Collaboration, 2014).
The second approach is to split the shared group into subgroups of (nearly) equal size, one for each treatment. For the example, this is applied to the placebo group.
Again, in the case of a binary outcome, this is straightforward, except that the total number of events or sample size may not be possible to split into equal parts according to the number of active treatment arms (in the extreme, we can have a study with less events in the control group than the number of active study arms).
For a continuous outcome, only the total number of participants is divided up, assuming equal means and standard deviations in all subgroups. This approach is not generally recommended, as only the unit-of-analysis error is avoided, while the groups are still correlated because the means are equal.
Another approach mentioned in the Cochrane Handbook is to include two or more correlated comparisons in the meta-analysis and account for the correlation. The final proposal is to conduct a multiple treatment meta-analysis, also called network meta-analysis, which generalizes pairwise meta-analysis to more than two treatments. In this respect, it goes beyond the scope of a systematic review that aims at comparing two interventions, based on pairwise meta-analysis. Following this recommendation of the Handbook means shifting the research question from a pairwise comparison to a multiple treatment comparison. The approach is therefore more than just another adjusting method. Because in network meta-analysis all comparisons provide information, the analysis benefits from full information, but must account for the correlation between three or more comparisons within the same trial.
Appropriate methods of network meta-analysis adjust for the correlation between multiple comparisons within multi-arm studies (Franchini et al., 2012; Rücker and Schwarzer, 2014) .
The objective of this tutorial is to present five approaches (three of which have been mentioned above), to demonstrate their application on three selected data sets, and to discuss their scope of application as well as their advantages and limitations.
Particularly, we add a novel approach (Method 4 below) that to the best of our knowledge has not been presented before.
The paper is organised as follows. In section 2, the data examples are presented, the first with a binary outcome, the second with a continuous outcome and the third with a survival outcome. In section 3, subsection 3.1, three different potential purposes of a meta-analysis are listed. In subsection 3.2, the five methods are described and illustrated by applying them to the first example. In subsection 3.3 we discuss how to proceed if some information is missing. In section 4 all methods are applied to the other two examples. The paper concludes with a discussion and some recommendations in section 5.
2 Data sets
Pelargonium sidoides data
Our first data example comes from a Cochrane review comparing pelargonium sidoides, also known as Umckaloabo, for treatment of acute respiratory infections to placebo (Timmer et al., 2013) . One of the trials included was a four-arm trial with three different treatment arms and a placebo arm (Kamin et al., 2010) . The outcome is 'Failure to recover by day seven' (i.e., complete resolution of all symptoms), dichotomous data are shown in Table 1 . In the Cochrane review the 'Splitting the shared group' approach was used and the trial was reported as three substudies (10 mg, 20 mg, 30 mg), each compared with a third of the number of controls. This data set serves for illustration of all methods in this section of the tutorial. 
Acupuncture data
In a three-arm trial (Linde et al., 2005) , acupuncture for migraine was compared to sham acupuncture and to a waiting list. To facilitate recruitment and increase the compliance of trial physicians, a 2:1:1 randomisation ratio was used. The primary outcome was the reduction in the number of days with headache of moderate or severe intensity between the 4 weeks before and weeks 9 to 12 after randomization, based on patients' diaries. Results are given in Table 2 . 
Breast cancer data
The last example comes from a three-arm phase III trial investigating the efficacy and safety of three combination treatments for human epidermal growth factor receptor 2 (HER2)-negative, locally recurrent or metastatic breast cancer (Miles et al., 2010) . The three arms were docetaxel 100 mg/m 2 plus bevacizumab 15 mg/kg (n = 247), docetaxel 100 mg/m 2 plus bevacizumab 7.5 mg/kg (n = 248), and docetaxel 100 mg/m 2 plus placebo (n = 241). The results for the primary endpoint progression-free survival (PFS) are given in Table 3 . surgery is necessary at all (illustrated by the title of a review 'To close or not to close: contemporary indications for patent foramen ovale closure ' Zier et al. (2016) ).
To give these scenarios a structure, we distinguish three common cases.
1. Two treatments are compared. The distinction between different modalities of the active treatment or subtypes of the control treatment is not important for the research question at hand.
2. Two treatments are compared, but it is also of interest whether the treatment modality or the type of control treatment makes a difference.
3. The meta-analysis is designed as a network meta-analysis to determine a rank order of benefit, and the literature search was designed to find studies comparing at least two of the eligible treatments.
In the first case one would likely prefer to combine the treatment groups or control groups. This leads to our Method 1, 'Combining groups'. In the second case, there are a number of different options. First, one could split up the shared group (in example 2.1, this is the placebo group) into a number of subgroups (e.g., three placebo subgroups, corresponding to the three doses of the active treatment) and include these as substudies in the meta-analysis. We call this Method 2 ('Splitting the shared group'). In the meta-analysis context, this enables meta-regression, using the factor defining the subgroups (e.g., dosage) as a covariate. Alternatively, instead of formally splitting up the shared group, one could compare each treatment subgroup to the full group, but account for multiplicity by appropriately adjusting the standard error. There are two ways for doing this, which we call Method 3 ('Approximate adjustment') and Method 4 ('Exact adjustment'). In the third common case, it is possible to conduct a network meta-analysis, which we call Method 5 ('Network meta-analysis'). In the next subsection we describe all five methods in more detail and illustrate each of them practically by application to the first data set, 2.1.
Methods for including multiple groups into a meta-analysis Method 1: 'Combining groups'
For a binary outcome, as in the first example data set, combining, i.e., merging the groups simply means adding the numbers of events and total participants over all
groups. This provides the data in Table 4 and leads to a risk ratio ( Section 7.7.3.8 of the Cochrane Handbook (Table 7 .7.a) provides formulas for calculating mean and standard deviation in case of a continuous outcome, if summary data over all groups or individual patient data are not available. Given the sample sizes n 1 , n 2 , the meansx 1 ,x 2 and the standard deviations SD 1 , SD 2 , we obtain for the combined group n comb = n 1 + n 2 (1)
If we have arm-based survival data for two (or more) arms in form of Kaplan-Meier curve estimates or numbers of events and numbers at risk for all time points, these arms can be combined in a straightforward way. For detailed methods of extraction for survival data, see Parmar et al. (1998); Tierney et al. (2007) .
Method 2: 'Splitting the shared group'
This method was applied in the Cochrane review that included the study of the first example. The control group was randomly split in three groups, leading to the data in This method has been proposed by one of the authors of this tutorial (Cates, 2015) , and can be used to avoid unit of analysis errors when including multi-arm trials in a generic inverse variance meta-analysis. It is based on the following consideration.
Instead of formally splitting up the shared group into groups of (nearly) equal size and (nearly) equal numbers of events, we could compare each active group to the full control group, but increase the standard error of this comparison by an appropriate factor. This can be derived as follows.
Let k be the total number of arms in the study including the control arm. In our example, we have k = 4. Comparing each active arm to the kth group (the control group), we observe variance estimates v ik for all k − 1 pairwise comparisons of arm i to arm k. These can be assumed to be sums of the respective arm-based sampling variances s 2 i and s
Splitting the control group into k − 1 equal parts means increasing the variance in the control group, s 2 k , by the factor k − 1. Accounting for multiple use of the control group therefore means that we have to consider the adjusted variances
instead of v ik . The variance of the naïvely pooled common effect estimate is
and the variance of the pooled common effect estimate based on the adjusted variances is
We obtain for the variance inflation factor
If all arms including the control arm are of approximately equal size, we may estimate the variance inflation factor by assuming that all within-group standard errors are equal, that is, s 
Method 4: 'Exact adjustment'
Method 3 is an approximate method, because it is based on the simplifying assumption that the standard errors in all arms were equal. However, this might not be the case if the arms are of different size. It is particularly questionable in the case of binary data if the number of events varies across arms, as the variance also depends on the number of events. To overcome this, we propose to adjust the standard errors by exact inflation factors that can be derived using a method that was developed for adjusting the standard errors of multi-arm studies in network meta-analysis (Rücker and Schwarzer, 2014) . The method basically reverses what happens with the variances in a multi-arm study. Whereas precision in multi-arm studies benefits from multiple comparisons, we have to reverse this when using only a part of the comparisons.
For a k-arm study we have k(k − 1)/2 comparisons. We consider the variances of all pairwise comparisons of arms i and j with arm-based sampling variances s 2 i and s
For the k-arm study we now define the full design matrix X with dimension k(k − 1)/2×k. As all effects are determined by the k −1 contrasts to an arbitrary reference treatment, X has rank k − 1. For example, for k = 4 we have k(k − 1)/2 = 6 and
with rank 3. Let V be a k × k matrix containing the k(k − 1)/2 contrast-based sampling variances v ij , ordered in the following way (example for k = 4):
Then the matrix L defined by
(where the + symbol denotes the pseudoinverse operator (Albert, 1972) ) contains as off-diagonal elements the negative inverses of the inflated variances, ordered in the same way as in V (Xiao and Gutman, 2004; Rücker, 2012; Rücker and Schwarzer, 2014 ).
For arbitrary k we provide R code, based on the R package netmeta, in Appendix We note that Method 4 not only corrects the standard errors, but also adjusts for the correlation between multiple comparisons within the same study (Rücker and Schwarzer, 2014) .
Method 5: 'Network meta-analysis'
Network meta-analysis is an extension of pairwise meta-analysis, used to compare three or more treatments for a given medical condition, based on combining information from all existing comparisons among the treatments from a number of studies (Salanti, 2012; Rücker, 2016) . Typically, also multi-arm studies are included. One or more studies comparing different dosages (say) to each other and/or placebo can be pooled in a network meta-analysis, providing amalgamated direct and indirect evidence for each possible comparison. For the pelargonium sidoides data, network meta-analysis would be of particular interest if there were more studies reporting results stratified by dosage. Figure 4 shows the result for our pelargonium sidoides study, interpreted as a network meta-analysis of a single study. The standard errors are not adjusted, as the arms are not merged or split. We do not go into more detail here, as this is beyond the scope of this article in which our main focus is on pairwise meta-analysis.
Missing information
In the pelargonium sidoides example we have full information for all arms. In practice, however, information may be missing, particularly in case of a continuous outcome. Often only contrast-based variances are known, and not all of them are reported in the primary studies. In this subsection, we consider such situations and show which methods can be chosen.
All contrast-based sampling variances known
If variances are provided for all possible contrasts (comparisons), we know matrix V as in equation (5) and can use methods 3 (approximate adjustment) and 4 (exact adjustment). In this case it is possible to derive all arm-based variances, as shown in Appendix C. If the treatment effects are also available for all contrasts, one can set one arm effect, considered as a baseline (for example, the placebo effect), formally to zero (or any other value, because this value cancels out). Then all other arm-based responses are determined, and we can continue as if having full information and also use methods 1 (combining groups), 2 (splitting the shared group), and 5 (network meta-analysis).
Only a subset of the contrast-based sampling variances known
If not all contrast-based sampling variances are known, but only those that compare each treatment to the control, we either may use method 3 (approximate adjustment) or use method 4 (exact adjustment) after imputing missing information. We show how the latter works for k = 3. Assume we know the variances v 13 and v 23 . Then we may estimate v 12 by v 12 = (v 13 + v 23 )/2 and use exact adjustment.
Alternatively, and particularly if the arms are of different sizes n 1 , n 2 , n 3 , we could suppose a common standard deviation SD for all arms and assume
Equations 7 and 8 provide SD 2 = v 13 n 1 n 3 n 1 + n 3 SD 2 = v 23 n 2 n 3 n 2 + n 3 and we may estimate SD 2 as a mean from these:
Inserting this in (6) we obtain
Table 6 summarises when each method can be applied. 
Application to the other data sets
In this section we apply the different methods to the other two example data sets.
Acupuncture data
Suppose that a meta-analysis of 'all types of acupuncture versus no treatment' would consider studies of either 'acupuncture versus waiting list' or studies of 'sham acupuncture versus waiting list' to be eligible for inclusion.
Method 1: 'Combining groups'
As the outcome 'reduction in days with moderate or severe headache' is a continuous outcome, we have to use the formulas given in section 7.7.3.8 of the Cochrane Handbook (Table 7 .7.a) for combining the acupuncture and the sham acupuncture group. Given the sample sizes n 1 , n 2 , the meansx 1 ,x 2 and the standard deviations SD 1 , SD 2 from Table 2 and using equations (1) to (3), we obtain for the combined 
Method 4: 'Exact adjustment'
Choosing method 4 'Exact adjustment', we can use the R package netmeta to calculate the exact inflated standard errors (R code see Appendix A), or, alternatively, we can calculate the inflated standard errors using the formulas in Appendix B.
Using the latter method we obtain S = 0.5(2 · 0.37 2 · 0.32 2 + 2 · 0.37 2 · 0. (Figure 7) . We note that the exact variance inflation factors for the three comparisons (1.61, 1.29, 1.66) differ from their approximate value of 3/2 due to the unbalanced group sizes.
For this reason the exact adjustment method best reproduces the result from the 'Combining groups' approach.
Method 5: 'Network meta-analysis' Figure 8 shows the results of network meta-analysis applied to the acupuncture data, with 'waiting list' as reference. As for the pelargonium sidoides data, this analysis simply reproduces the result of the three-arm study without adjustment, as no merging or splitting of groups is necessary or intended.
Breast cancer data
The breast cancer data are an example of missing information. We have only contrast-based information (hazard ratios) for two of the three comparisons, docetaxel 100 + bevacizumab 15 and 7.5, respectively, vs docetaxel 100 + placebo.
Thus, to compare bevacizumab in either dosage to docetaxel alone, the arm-based methods 1 and 2 are not possible. We may use the contrast-based methods 3 (ap-proximate adjustment) or 4 (exact adjustment, that requires imputation of further information, using methods from subsection 3.3). 
Method 4: 'Exact adjustment'
The variance of the missing comparison (bevacizumab 15 vs bevacizumab 7.5) can be estimated using equation (9). We obtain 0.0939 for the missing contrast-based standard error. We may now use the R code in appendix A or the formulas in appendix Method 5: 'Network meta-analysis' Figure 11 shows the results of network meta-analysis applied to the breast cancer data, with docetaxel 100 + placebo as reference. Again, this analysis almost reproduces the result of the three-arm study.
Pairwise meta-analysis still dominates the literature of systematic reviews. Even in reviews using network meta-analysis as primary analysis, pairwise meta-analyses are routinely conducted and also additionally requested by recent guidelines (Puhan et al., 2014; Caldwell et al., 2016) . In addition to network meta-analysis, which is designed for comparing more than two treatments in a systematic review, we have presented four methods for including multiple arms from a multi-arm study in a pairwise meta-analysis. Some type of adjustment is necessary when doing this to avoid a unit-of-analysis error.
We distinguished different purposes for including multiple arms. If some arms are to be combined, as their distinction is not relevant for the research question at hand, the 'Combining groups' method can be chosen. If one decides to analyse the arms separately, one should choose one of the other methods (splitting the shared group, approximate adjustment, exact adjustment, or network meta-analysis). Whereas approximate adjustment is always possible, group-splitting, exact adjustment and network meta-analysis make some requirements with respect to data availability.
We showed how missing information can be imputed, if necessary.
If the common effect model (traditionally called fixed effect model) is used for pooling, the relative weight of a multi-arm study does not depend on whether its arms are combined (Method 1) or split up (Methods 2, 3, and 4). When using the random effects model, however, the relative weight of each study may depend on the method for adjusting. Suppose, for example, that there is heterogeneity between the comparisons of different active arms of a multi-arm study to a common control.
This heterogeneity is hidden if these arms are combined (Method 1), but it becomes apparent if the control group is split up (Methods 2, 3, and 4). Accordingly, the estimate for the between-study variance τ 2 may change when using one of these methods, which in turn affects all random effect weights, also those of other studies.
Furthermore, if a control arm is split up into two or more parts, τ 2 enters more than one line in the data, and the study will effectively obtain more weight in the metaanalysis (particularly if τ 2 is large compared to the study variance) in comparison to combining the active arms. For this reason, we explicitly discourage using Methods 2, 3, and 4 when using the random effects model.
Conclusion
If a pairwise meta-analysis is planned based on the common effect model, we recom- A R code for approximate and exact adjustment
In practice, if all variances are given or imputed, determining inflation factors for arbitrary k is possible using the R package netmeta for network meta-analysis. We show R code for the pelargonium sidoides example.
# Install package netmeta and make it available in R session
install.packages("netmeta") library(netmeta)
# Data set by Kamin et al. (2010) kamin <-data.frame(study = rep ( B Determining inflated variances for k = 3
In this subsection, we show how to obtain exactly adjusted standard errors by hand for and is a special case of the general case of k arms, where the average weight reduction factor is 2/k (Rücker 2012) . The inverse of the average weight reduction factor, here 3/2 (in general k/2) is thus the harmonic mean of the variance inflation factors.
C Determining arm-based variances from contrastbased variances
If variances are provided for all possible contrasts, we can derive arm-based variances from these. This works as follows. For a k-arm study, the design matrix X is that of a complete graph of k vertices and k(k − 1)/2 edges as in equation (4). Taking the first k rows of its absolute version |X|, we obtain a quadratic matrix, such as
with rank k (here k = 4). Taking the first k of the contrast-based variances, arranged in the same order as in matrix V (equation (5) Figure 11 : Network meta-analysis of the breast cancer data.
